News
Hikma licenses Chiesi Group’s respiratory and neonatal products for Egyptian market
News
Hikma and Arecor announce exclusive agreement to develop and commercialise ready-to-use medicine using Arestat™ technology
News
Hikma joins 50th World Economic Forum Annual Meeting in Davos, Switzerland
Our impact
The impact we have on people's lives is important, positive and far-reaching, listen to the stories of people whose lives we touch.
Case study
Our support and impact for the Healthy Kitchen Project
Case study
Our support and impact; improving patient’s access to ritonavir
News
Hikma provides an update on the status of its ANDA for generic Advair Diskus®
Case study
Medicine donations put better health in reach for patients in need
Find out more
Who we are. We make high quality medicines and make them accessible to the people that need them.
News
Civica Rx and Hikma announce shipments of Heparin and seven other essential injectable medicines
Find out more
Our commitment to sustainability
Find out more
We develop, manufacture and market nearly 700 quality branded and non-branded generic medicines worldwide.